BioGaia has today signed an exclusive agreement with VietPhap International Co
Ltd for the rights to sell BioGaia ProTectis Drops in Vietnam. The launch is
planned to take place during 2015.
VietPhap International Co Ltd is one of the leading pharmaceutical companies in
Vietnam. The company is doing licensing, business development, marketing, sales
and distribution of a wide range of products, both over-the-counter and
prescription drugs, in many different indication areas. VietPhap markets its
products towards health care professionals.
VietPhap will market BioGaia ProTectis Baby Drops, BioGaia’s biggest product,
and later also launch BioGaia ProTectis Baby Drops with vitamin D. Both products
contain the patented and well-documented probiotic strain Lactobacillus reuteri
Protectis. Today the drops are sold in 70 countries worldwide.
Vietnam has 90 million inhabitants and a low, but rapidly growing, purchasing
power per capita.
"Asia is a market with great potential and I am pleased that BioGaia’ products
will be available in yet another country here. With the reputable local partner
VietPhap we hope for a successful launch of our paediatric portfolio in
Vietnam", says Peter Rothschild, President, BioGaia.
Latest press releases from BioGaia
2014-12-11 BioGaia product effective in constipated adults
2014-12-01 BioGaia invests in promising research company
2014-10-24 Infants with colic cry less with BioGaia with BioGaia’s drops
BioGaia has published this information in accordance with the Swedish Securities
Market Act. The information was issued for publication on 12 January 2015, 09:45
am CET.
For additional information please contact
Peter Rothschild, Chief Executive Officer, BioGaia: 46 8 555 293 00
BioGaia is a healthcare company that develops, markets and sells probiotic
products with documented health benefits. The products are primarily based on
the lactic acid bacterium Lactobacillus reuteri, which has probiotic, health
-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted
on the Mid Cap list of the NASDAQ OMX Nordic Exchange Stockholm. www.biogaia.com
